Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies

被引:22
作者
Vio, Riccardo [1 ]
Angelini, Annalisa [1 ]
Basso, Cristina [1 ]
Cipriani, Alberto [1 ]
Zorzi, Alessandro [1 ]
Melacini, Paola [1 ]
Thiene, Gaetano [1 ]
Rampazzo, Alessandra [2 ,3 ]
Corrado, Domenico [1 ]
Calore, Chiara [1 ]
机构
[1] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, I-35128 Padua, Italy
[2] Univ Padua, Dept Biol, I-35131 Padua, Italy
[3] Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy
关键词
hypertrophic cardiomyopathy; restrictive cardiomyopathy; cardiomyopathies; restrictive physiology; genetics; heart failure; amyloidosis; Fabry disease; glycogen storage diseases; LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; ANDERSON-FABRY-DISEASE; LATE GADOLINIUM ENHANCEMENT; ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA DATA; CLINICAL PROFILE; EUROPEAN-SOCIETY; ADULT PATIENTS; HEART-FAILURE;
D O I
10.3390/jcm10091954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM) and primary restrictive cardiomyopathy (RCM) have a similar genetic background as they are both caused mainly by variants in sarcomeric genes. These "sarcomeric cardiomyopathies" also share diastolic dysfunction as the prevalent pathophysiological mechanism. Starting from the observation that patients with HCM and primary RCM may coexist in the same family, a characteristic pathophysiological profile of HCM with restrictive physiology has been recently described and supports the hypothesis that familiar forms of primary RCM may represent a part of the phenotypic spectrum of HCM rather than a different genetic cardiomyopathy. To further complicate this scenario some infiltrative (amyloidosis) and storage diseases (Fabry disease and glycogen storage diseases) may show either a hypertrophic or restrictive phenotype according to left ventricular wall thickness and filling pattern. Establishing a correct etiological diagnosis among HCM, primary RCM, and hypertrophic or restrictive phenocopies is of paramount importance for cascade family screening and therapy.
引用
收藏
页数:17
相关论文
共 110 条
[91]   Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping [J].
Sado, Daniel M. ;
White, Steven K. ;
Piechnik, Stefan K. ;
Banypersad, Sanjay M. ;
Treibel, Thomas ;
Captur, Gabriella ;
Fontana, Marianna ;
Maestrini, Viviana ;
Flett, Andrew S. ;
Robson, Matthew D. ;
Lachmann, Robin H. ;
Murphy, Elaine ;
Mehta, Atul ;
Hughes, Derralynn ;
Neubauer, Stefan ;
Elliott, Perry M. ;
Moon, James C. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (03) :392-398
[92]   Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis [J].
Sethi, Sanjeev ;
Vrana, Julie A. ;
Theis, Jason D. ;
Leung, Nelson ;
Sethi, Anjali ;
Nasr, Samih H. ;
Fervenza, Fernando C. ;
Cornell, Lynn D. ;
Fidler, Mary E. ;
Dogan, Ahmet .
KIDNEY INTERNATIONAL, 2012, 82 (02) :226-234
[93]   Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death [J].
Shirani, J ;
Pick, R ;
Roberts, WC ;
Maron, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :36-44
[94]   High incidence of later-onset Fabry disease revealed by newborn screening [J].
Spada, Marco ;
Pagliardini, Severo ;
Yasuda, Makiko ;
Tukel, Turgut ;
Thiagarajan, Geetha ;
Sakuraba, Hitoshi ;
Ponzone, Alberto ;
Desnick, Robert J. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (01) :31-40
[95]   RELATION BETWEEN EXTENT OF LEFT-VENTRICULAR HYPERTROPHY AND OCCURRENCE OF SUDDEN CARDIAC DEATH IN HYPERTROPHIC CARDIOMYOPATHY [J].
SPIRITO, P ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (07) :1521-1526
[96]   ABSENCE OF PROGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN ADULT PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY [J].
SPIRITO, P ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (05) :1013-1017
[97]   Twenty years of progress and beckoning frontiers in cardiovascular pathology - Cardiomyopathies [J].
Thiene, G ;
Basso, C ;
Calabrese, F ;
Angelini, A ;
Valente, M .
CARDIOVASCULAR PATHOLOGY, 2005, 14 (04) :165-169
[98]   Cardiomyopathies: is it time for a molecular classification? [J].
Thiene, G ;
Corrado, D ;
Basso, C .
EUROPEAN HEART JOURNAL, 2004, 25 (20) :1772-1775
[99]  
Thiene G., 1989, EUR HEART J, V10
[100]  
Thiene G, 2008, EUR HEART J, V29, P144